Morphine Market Share

North American Market Statistics

The morphine market in the North America region is projected to observe the largest market revenue with a share of 35 percent throughout 2023 - 2037. This can be attributed to the increasing patient pool of osteoporosis. According to the statistics of the Centers for Disease Control and Prevention, 4.2% of men and 18.8% of women over the age of 50 years suffered from osteoporosis of the femur neck or lumbar spine.  Moreover, a high share of the geriatric population in countries, such as the United States and Canada, is estimated to boost the regional market growth. In addition, a rise in research collaboration numbers is among the factors anticipated to boost market expansion. Due to its pro-healthcare legislation, the United States has the largest share in this area.

APAC Market Analysis

In Asia Pacific, the morphine sector is assumed to witness a substantial market extension of 28 percent by the end of 2037. The increasing investment in the healthcare sector and rising awareness about palliative care medication in the region are expected to drive market growth in the Asia Pacific region.  Some countries such as India, and China have well-developed healthcare infrastructure with proper pain management medications such as morphine use, but at the same time, few regions still working on implementing these chronic disease management solutions that include chronic pain management in the region. As per the India Brand Equity Foundation, the government of India is planning to launch a credit incentive program to boost the healthcare infrastructure accounting for USD 6.8 billion.